The Breast Cancer Research Foundation
MEET OUR RESEARCHERS WORLDWIDEresearch on cancer formationresearch on cure and preventionour scientific advisorsresearcher profilesscience newsIn the Spotlight: BCRF Scientific Leaders Comment on the Latest Breast Cancer HeadlinesBCRF Ramps Up Focus on Metastatic Breast CancerBCRF Scientific Leaders Comment on USPSTF Chemoprevention RecommendationsIn Her Own Words: Titia de Lange, PhDSecond Collaborative Summit on Breast Cancer ResearchPrevention and Environmental Factors Implicated in Breast Cancer2012 San Antonio Breast Cancer SyposiumGenetic Changes Found in Breast Cancers Confirm Modern Classification2012 ASCO Breast Cancer Symposium2012 Annual Meeting of the American Society of Clinical Oncology (ASCO)Tribute to Evelyn H. Lauder at ASCO 2012Potential marker to predict effectiveness of platinum-based chemotherapiesBCRF grantees elected to lead international cancer organizationsTribute to Evelyn H. Lauder at SABCS 20112011 San Antonio Breast Cancer Symposium (SABCS)Clifford Hudis, MD Elected ASCO PresidentBreaking News from 2011 San Antonio Breast Cancer Symposium, December 6-102011 ASCO Breast Cancer Symposium videos2011 Annual Meeting of the American Society of Clinical Oncology (ASCO) Feb 2011: "Revolutionizing Our Approach to Breast Cancer" Feb 2011: New Lymph Node Study2010 San Antonio Breast Cancer SymposiumBCRF Grantee, Dr. Silvia Formenti, Receives Honor from Home Institution2010 ASCO Breast Cancer Symposiumsymposia and scientific retreatsresearch accomplishmentswhat our researchers say about BCRF the Jill Rose awardmajor donor awardsgrant guidelinesclinical trials

resourcespresssearchcontact usdonate now

Research Saves Lives!

Support Lifesaving Research
Hour by Hour

By creating your own fundraiser
about BCRF research in action partners+programseventsget involved
emailprint

Cancer Stem Cell Drug to be Tested in Patients

BCRF researcher Michael Clarke, MD, identified breast cancer stem cells in 1994. His discovery sparked a new line of reasoning about the tenacity of cancer.
Now, a drug that was developed for Alzheimer's disease but has been proven to kill breast cancer stem cells in laboratory studies will be given to 30 women with advanced breast cancer, the New York Times reported in an article on 12/21/07.

The study, led by Clarke's colleague, Dr. Max S. Wicha of the University of Michigan, will test the safety of this drug and help further determine stem cells' role in cancer. While the stem cell hypothesis as a cause in cancer has been debated since Clarke and Wicha established their existence, BCRF's Dr. Robert Weinberg of MIT told the New York Times that theirs "...is conceptually the most important paper in cancer in the past decade."

Read more about BCRF-funded research under the direction of Dr. Michael Clarke and Dr. Robert Weinberg.


Make A Difference:

join us on facebookfollow us on twitterstay informedsend a tribute ecardhost a fundraiser
support research


homesite mapsearchtermsprivacy policycontact us© 2013 The Breast Cancer Research Foundation